Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19

Table 1

General characteristics of patients with COVID-19.

Variables	Number of patients	Proportion (%)
Sex
Male	15	45.0
Female	18	55.0
Age
0-6 years	0	0
7-17 years	4	12.1
18-40 years	6	18.2
41-65 years	18	54.6
≥66 years	5	15.6
Comorbidity
Hypertension	5	15.2
Diabetes	2	6.1
Clinical classification
Mild	3	9.1
Ordinary	30	90.9
Residence
Hubei	18	55.0
Yunnan	15	45.0
Lymphocyte absolute value after admission (normal: /L)
Normal	28	84.9
Reduced	5	15.2
CD3+ T cell after admission (normal: 1027-2086/μL)
Normal	20	60.6
Reduced	13	39.4
CD4+ T cell after admission (normal: 706-1125/μL)
Increased	2	6.1
Normal	5	15.2
Reduced	26	78.8
CD8+ T cell after admission (normal: 323-836/μL)
Normal	16	48.5
Reduced	17	51.52
Treated with glucocorticoids
Yes	13	39.4
No	20	60.6